MENU
CYDY
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION
CytoDyn (CYDY) Ownership - Who owns CytoDyn?
CytoDyn Inc is a USA-based clinical-stage biotechnology company that focuses on the clinical development and potential commercialization of humanized monoclonal antibodies to treat Human Immunodeficiency Virus (HIV) infection... Show more
Profile
Industry
N/A
Address
1111 Main Street
Phone
+1 360 980-8524
Employees
12
Web
https://www.cytodyn.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
322.31M
P/E Ratio
N/A
Total Cash
11.9M
Projected Growth
N/A
Total Debt
27.34M
Revenue
N/A
Risk (Beta)
1.84
Dividend Yield
N/A
Total Cash/Share
0.01
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
CYDY
Capitalization
322M
P/E Ratio
N/A
Risk (Beta)
1.84
Dividend Yield
N/A
Total Cash
11.9M
Total Cash/Share
0.01
Total Debt
27.3M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
-96.04M
P/B Ratio
N/A
Cash Flow
N/A
Earnings
0
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.25M
Current Ratio
0.25
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
8.59M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
15.50
Shares Held By Institutions
66.6K
Shares Outstanding - Current
1.25B
Total Liabilities
114M
Total Volume MTD
N/A
Value
1
Gain YTD
134.754
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1111 Main Street
Phone
+1 360 980-8524
Employees
12
Web
https://www.cytodyn.com